EDSA Edesa Biotech Inc Net earnings per share growth forecast for next year
Demand for immunotherapy remains independent of economic cycles, as evidenced by the expected EPS growth for Edesa Biotech, Inc. (EDSA) next year, where the indicator level is -4.00. These prospects are based on compliance with bioethics and environmental standards. However, ultimate success depends on the patent protection of inhibitors and the results of final clinical trials, which carry certain binary risks.
Analytical breakdowns for edesabiotech.com (EDSA)
- stock quotes and analyst forecast:
- market capitalization data:
- company book value details:
- debt obligations and liquidity statistics:
Total Debt to Capital Edesa Biotech, Inc.|EDSA - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Edesa Biotech|EDSA - Company Cumulative Debt|Debt to Book Capitalization Ratio Edesa Biotech|EDSA - Long-Term Debt Volume|Company Short-Term Debts Edesa Biotech|Quick Liquidity Indicator edesabiotech.com
- earnings and valuation multiples information:
EDSA - Final Profit|Projected Future Earnings Edesa Biotech, Inc.|EDSA - Price to Earnings Ratio|Forward P/E Multiple Edesa Biotech, Inc.|EDSA - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Edesa Biotech|EDSA - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Edesa Biotech|EDSA - Earnings per share for the last four quarters|Quarterly EPS earnings growth edesabiotech.com|EDSA - Earnings per share growth rate in current year|Earnings growth forecast for next year Edesa Biotech, Inc.
Fundamental company analysis:EDSA, Edesa
Edesa Biotech, Inc. (EDSA) development of a universal ARDS therapy that modulates the immune response defines the commercialization potential of its biopharmaceutical solutions. This metric aggregates analyst consensus forecasts for earnings per share (EPS) changes, measuring the expected year-over-year net income dynamics. Analyzing the forward-looking vector of EPS growth estimates allows investors to timely adjust asset valuation based on the current market reassessment of business sustainability.
Competitor analysis
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year BioNTech Pharma|Net earnings per share growth forecast for next year Abivax (ABVX)|admabiologics.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (Protagonist)|Immunovant Inc (IMVT) - Expected net earnings per share growth next year|Kiniksa Pharmaceuticals Ltd - Earnings growth forecast for next year|Expected net earnings per share growth next year Grifols Biemat|ADPT: Earnings growth forecast for next year|Projected earnings per share growth rate for next year CLDX|AUPH (Aurinia Pharmaceuticals Inc.) - Earnings growth forecast for next year|Expected net earnings per share growth next year BioCryst Pharmaceuticals, Inc. BCRX|Net earnings per share growth forecast for next year Vera Pharma (VERA)|Consensus forecast of earnings per share growth for next year Dianthus Corp|Earnings growth forecast for next year PHVS (Pharvaris N.V.)|Earnings growth forecast for next year abcellera.com ABCL|TRML: Expected earnings per share growth for next year|Expected earnings per share trend next year PGEN (Precigen Inc)|PHAR: Earnings growth forecast for next year|NKTR (Nektar Corp) - Net earnings per share growth forecast for next year|UPB (Upstream Bio Inc) - Earnings growth forecast for next year|zenasbio.com (ZBIO) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Immunome (IMNM)|GOSS - Expected net earnings per share growth next year|KalVista Pharmaceuticals Inc - Expected earnings per share growth for next year|Projected earnings per share increase next year SEPN (Septerna Pharma)|Pieris Pharmaceuticals - Earnings growth forecast for next year|Expected net earnings per share growth next year savarapharma.com|RIGL: Earnings growth forecast for next year|Expected earnings per share growth for next year AnaptysBio Inc|ATXS (Astria Pharma) - Earnings growth forecast for next year|ENGN: Expected earnings per share trend next year|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|JBIO (aerovatetx.com) - Expected earnings per share trend next year|Earnings growth forecast for next year ACRS (Aclaris Therapeutics, Inc.)|Consensus forecast of earnings per share growth for next year Kyverna Therapeutics Inc. (KYTX)|TLSA - Net earnings per share growth forecast for next year|CABA (Cabaletta Bio Inc) - Projected earnings per share growth rate for next year|VTYX: Earnings growth forecast for next year|Expected earnings per share growth for next year theratech.com|Expected earnings per share growth for next year AVTX|Eledon Pharmaceuticals Inc. (ELDN) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year AGEN|CLYM - Expected net earnings per share growth next year|Earnings growth forecast for next year ZURA (Zura Bio Limited)|ATYR: Projected earnings per share growth rate for next year|ADAG - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year ImageneBio Inc IMA|STTK: Earnings growth forecast for next year|Equillium (EQ) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year Connect Biopharma Holdings|Immunic Inc - Net earnings per share change forecast for next year|Earnings growth forecast for next year ATRA|IFRX (inflarx.de) - Expected earnings per share trend next year|Earnings growth forecast for next year XFOR (X4 Pharma)|Earnings growth forecast for next year Adicet Bio Inc. ACET|CELU - Net earnings per share growth forecast for next year|Expected earnings per share trend next year INMB (inmunebio.com)|Barinthus Biotherapeutics plc (BRNS) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year Kezar Life Sciences Inc.|SABS (SAB Biotherapeutics, Inc) - Earnings growth forecast for next year|Earnings growth forecast for next year Akari Therapeutics, Plc|Expected earnings per share growth for next year ENLV (Enlivex Therapeutics)|QTTB (q32bio.com) - Expected earnings per share trend next year|Earnings growth forecast for next year GOVX (GeoVax)|Consensus forecast of earnings per share growth for next year iBio Inc (IBIO)|CARM - Net earnings per share growth forecast for next year|XTL Bio (XTLB) - Expected earnings per share growth for next year|boltbio.com (BOLT) - Net earnings per share growth forecast for next year|Expected earnings per share growth for next year HCW Biologics|Expected earnings per share growth for next year APVO|Earnings growth forecast for next year AIM ImmunoTech, Inc.|Net earnings per share growth forecast for next year Aditxt (ADTX)|GRI Bio Corporation - Projected earnings per share growth rate for next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc.)|reshapelifesciences.com (HIND) - Expected net earnings per share growth next year|Revelation Biosciences, Inc. - Earnings growth forecast for next year|Expected net earnings per share growth next year Indaptus Therapeutics Inc|SCNI: Earnings growth forecast for next year|Projected earnings per share growth rate for next year CALI|AFMD (Affimed NV) - Earnings growth forecast for next year|Expected net earnings per share growth next year Allakos Therapeutics ALLK|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|Consensus forecast of earnings per share growth for next year igmbio.com|Earnings growth forecast for next year ITOS (iTeos)|Earnings growth forecast for next year Ocean Biomedical Corp OCEA|TCBP: Expected earnings per share growth for next year|Expected earnings per share trend next year THRD (thirdharmonicbio.com)
